InauguralInvitation Only
Mast Cell & Eosinophil Disorders
USFocus Meeting 2027
Two days, 42 people, one room.
End of March 2027
San Antonio, TX
Dates
End of March 2027
Two-day program
Venue
San Antonio, TX
Hotel TBD
Audience
42 by invitation
21 KOLs & 21 fellows
Format
6 sessions · 21 talks
Keynote, talks + discussions
A Curated Room: The People Shaping Practice
This inaugural, invitation-only meeting convenes a deliberately small faculty: 21 leading mast cell and eosinophil KOLs alongside 21 hand-selected fellows and junior faculty, the allergists, hematologists and pathologists defining today’s standards and the ones who will define the next decade’s, in one room for two days.
The science tracks where treatment is moving: mast cell activation and anaphylaxis, diagnosis and treatment decisions in systemic mastocytosis, the symptom burden patients live with, the clinical overlaps that complicate diagnosis, a new era in food and drug allergy, and the pathways eosinophilic and IgE-driven diseases share. A keynote on mast cell disorders in children opens the program, and every session closes with open discussion.
Mast Cell Activation & IASystemic MastocytosisClonality & KIT TestingClinical Mimics: CSU & HATFood & Drug AllergiesHES · EoE · Hyper-IgE
Meeting Co-Chairs
Hussein Abbas
MD Anderson Cancer Center, Houston, TX
Joud Hajjar
Baylor College of Medicine, Houston, TX
Faculty Drawn From
MD Anderson · Mayo Clinic · Stanford · Brigham and Women’s · Walter Reed · National Institutes of Health and other leading US centers
42
Invited attendees only, sustained access, not a crowd
1:1
KOLs to rising faculty, a hand-picked balance in every session
14
Established US Focus Meetings behind it, a proven platform, not a one-off
Mast Cell & Eosinophil Disorders US Focus Meeting 2027
Faculty
Listed alphabetically by surname
Hussein Abbas
MD Anderson Cancer Center, Houston, TX
Cem Akin
University of Michigan, Ann Arbor, MI
Katherine Anagnostou
Baylor College of Medicine, Houston, TX
Nathan Boggs
Walter Reed National Military Medical Center, Bethesda, MD
Melody Carter
NIAID, National Institutes of Health, Bethesda, MD
Mariana Castells
Brigham and Women’s Hospital, Boston, MA
Jason Gotlib
Stanford Medicine, Stanford, CA
Matthew Greenhawt
Children’s Hospital Colorado, Aurora, CO
Joud Hajjar
Baylor College of Medicine, Houston, TX
Matthew Hamilton
Brigham and Women’s Hospital, Boston, MA
Thanh D. Hoang
Walter Reed National Military Medical Center, Bethesda, MD
David Khan
UT Southwestern Medical Center, Dallas, TX
Amy Klion
NIAID, National Institutes of Health, Bethesda, MD
Jon Lyons
UC San Diego, La Jolla, CA
Lauren Madigan
University of Utah, Salt Lake City, UT
Jennifer Marvin-Peek
MD Anderson Cancer Center, Houston, TX
Jennifer Nicoloro-SantaBarbara
Brigham and Women’s Hospital, Boston, MA
Thanai Pongdee
Mayo Clinic, Rochester, MN
Sarbjit Saini
Johns Hopkins Medicine, Baltimore, MD
Scott H. Sicherer
Icahn School of Medicine at Mount Sinai, New York, NY
Jonathan Spergel
Children’s Hospital of Philadelphia, PA
MD Anderson Cancer Center, Houston, TX
MD Anderson Cancer Center, Houston, TX
Massachusetts General Hospital, Boston, MA
Two Days, Six Sessions
Agenda
Presentations20 min
Panel Discussions20 min
30 min
20 min
65 min
Day One
Keynote: How to Manage Mast Cell Disorders in Children
Melody CarterNIAID, National Institutes of Health, Bethesda, MD
Session IMast Cell Activation and Anaphylaxis: From Recognition to Treatment
ModeratorTBD
MCAS: What It Is – and What It Isn’t
Matthew GreenhawtChildren’s Hospital Colorado, Aurora, CO
Mast Cell Biomarkers: What to Order, When, and How to Interpret
Thanai PongdeeMayo Clinic, Rochester, MN
Recurrent Anaphylaxis: When Is It Truly Idiopathic?
Katherine AnagnostouBaylor College of Medicine, Houston, TX
How Do I Manage MCAS
Cem AkinUniversity of Michigan, Ann Arbor, MI
Panel Discussion
Session IISystemic Mastocytosis: From Diagnosis to Treatment Decisions
ModeratorTBD
Diagnosing Systemic Mastocytosis: Putting the Pieces Together
Jason GotlibStanford Medicine, Stanford, CA
Beyond the Diagnosis: Assessing Risk and Response in Systemic Mastocytosis
Jennifer Marvin-PeekMD Anderson Cancer Center, Houston, TX
How I Treat Non-Advanced Systemic Mastocytosis: Who, When, and With What?
Nathan BoggsWalter Reed National Military Medical Center, Bethesda, MD
How I Treat Advanced Systemic Mastocytosis
Hussein AbbasMD Anderson Cancer Center, Houston, TX
Panel Discussion
Session IIILiving with Mast Cell Disorders: Symptoms, Complications, and Quality of Life
ModeratorTBD
Bone Health and Pain Management in SM
Thanh D. HoangWalter Reed National Military Medical Center, Bethesda, MD
Psychosocial & Neurologic Manifestations in Mast Cell Disorders
Jennifer Nicoloro-SantaBarbaraBrigham and Women’s Hospital, Boston, MA
Gastrointestinal & Nutritional Considerations in Mast Cell Disorders
Matthew HamiltonBrigham and Women’s Hospital, Boston, MA
Panel Discussion
ModeratorTBC
What ADCs Are: Beyond Target, Payload & Linker
Paolo TarantinoDana-Farber Cancer Institute, Boston, MA
Toxicities & Need for MDT: ILD, OM, Ocular
BJ RimelCedars-Sinai, Los Angeles, CA
Dose & Regimen Optimization, Including Duration
Bradley MonkFlorida Cancer Specialists, West Palm Beach, FL
Young Investigator Case Presentation
TBD
Panel Discussion
Day Two
Session IVClinical Overlap and Diagnostic Challenges
ModeratorTBD
Updates on CSU
Sarbjit SainiJohns Hopkins Medicine, Baltimore, MD
Hereditary Alpha-Tryptasemia: What Does the Diagnosis Mean?
Jon LyonsUC San Diego, La Jolla, CA
Differentiating Skin Manifestations of Allergic Diseases & Mast Cell Disorders
Lauren MadiganUniversity of Utah, Salt Lake City, UT
Panel Discussion
Session VFrom Restriction to Reintroduction: A New Era in Food and Drug Allergy
ModeratorTBD
Chemotherapeutic Drug Allergies
Mariana CastellsBrigham and Women’s Hospital, Boston, MA
Removing the Allergy Label
David KhanUT Southwestern Medical Center, Dallas, TX
Beyond Food Avoidance: Biologics and Oral Immunotherapy
Scott H. SichererIcahn School of Medicine at Mount Sinai, New York, NY
Panel Discussion
Session VIEosinophils and IgE: Shared Pathways, Different Diseases
ModeratorTBD
Overview of HES
Amy KlionNIAID, National Institutes of Health, Bethesda, MD
Eosinophilic Esophagitis and Gastroenteritis
Jonathan SpergelChildren’s Hospital of Philadelphia, PA
High IgE: When Is It More Than Allergy?
Joud HajjarBaylor College of Medicine, Houston, TX
Panel Discussion
ModeratorTBC
TCEs & Bispecifics
Oladapo YekuMassachusetts General Hospital, Boston, MA
Novel Small Molecules: KIF18A and Others
Shannon WestinMD Anderson Cancer Center, Houston, TX
ADCs with Multiple Targets and/or Multiple Payloads: Hope versus Hype
Patricia LoRussoYale Cancer Center, New Haven, CT
Young Investigator Case Presentation
TBD
Panel Discussion
Partnership Opportunities Now Open
Bespoke engagement packages for a closed, invitation-only audience
Request the Prospectus →